Siemens Healthineers (ETR:SHL) Given a €55.00 Price Target at Credit Suisse Group

Siemens Healthineers (ETR:SHL) has been given a €55.00 ($64.71) price target by analysts at Credit Suisse Group in a research note issued on Friday, Borsen Zeitung reports. The firm presently has a “buy” rating on the stock. Credit Suisse Group’s price objective would suggest a potential upside of 15.59% from the stock’s previous close.

Other equities research analysts also recently issued research reports about the company. DZ Bank reiterated a “neutral” rating on shares of Siemens Healthineers in a report on Tuesday, May 4th. Independent Research set a €51.00 ($60.00) price target on Siemens Healthineers and gave the stock a “neutral” rating in a report on Tuesday, May 4th. Barclays set a €47.00 ($55.29) price target on Siemens Healthineers and gave the stock a “neutral” rating in a report on Friday, April 30th. Berenberg Bank set a €56.00 ($65.88) price target on Siemens Healthineers and gave the stock a “buy” rating in a report on Thursday, April 29th. Finally, Nord/LB set a €56.00 ($65.88) price target on Siemens Healthineers and gave the stock a “buy” rating in a report on Wednesday, May 5th. Five equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. Siemens Healthineers currently has a consensus rating of “Buy” and an average target price of €51.48 ($60.56).

Shares of ETR:SHL opened at €47.58 ($55.98) on Friday. The company has a debt-to-equity ratio of 98.67, a current ratio of 2.60 and a quick ratio of 2.26. Siemens Healthineers has a twelve month low of €35.58 ($41.85) and a twelve month high of €49.99 ($58.81). The stock’s 50 day moving average price is €46.92. The firm has a market capitalization of $53.63 billion and a price-to-earnings ratio of 31.64.

About Siemens Healthineers

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and distributes imaging, diagnostic, and advanced therapies products and services to healthcare providers worldwide. The company operates through three segments; Imaging, Diagnostics, and Advanced Therapies. The Imaging segment offers magnetic resonance, computed tomography, X-ray, molecular imaging, and ultrasound systems.

Read More: What is the Shanghai Stock Exchange Composite Index?

Analyst Recommendations for Siemens Healthineers (ETR:SHL)

Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.